RecruitingNCT05751525

Impact of Sulphonylureas on Neurodevelopmental Outcomes in KCNJ11-related Intermediate Developmental Delay, Epilepsy and Neonatal Diabetes (iDEND) Syndrome

Studying Epilepsy syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Royal Devon and Exeter NHS Foundation Trust
Principal Investigator
Prof Andrew Hattersley
University of Exeter / Royal Devon University Healthcare Trust
Intervention
Sulfonylurea(drug)
Enrollment
21 enrolled
Eligibility
2-50 years · All sexes
Timeline
2016 – 2025

Study locations (4)

Collaborators

University of Chicago · University of Bergen · University of Rome Tor Vergata

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05751525 on ClinicalTrials.gov

Other trials for Epilepsy syndrome

Additional recruiting or active studies for the same condition.

See all trials for Epilepsy syndrome →

← Back to all trials